000			01879 a2200553 4500
005			20250516053336.0
264		0	_c20110920
008			201109s 0 0 eng d
022			_a0393-974X
040			_aNLM _beng _cNLM
100	1		_aCassano, N
245	0	0	_aAnti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease. _h[electronic resource]
260			_bJournal of biological regulators and homeostatic agents _c
300			_a285-9 p. _bdigital
500			_aPublication Type: Letter
650	0	4	_aAdalimumab
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnti-Inflammatory Agents _ximmunology
650	0	4	_aAntibodies _ximmunology
650	0	4	_aAntibodies, Monoclonal _ximmunology
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aCarrier State _ximmunology
650	0	4	_aDrug Combinations
650	0	4	_aEtanercept
650	0	4	_aFemale
650	0	4	_aHepatitis B _xdrug therapy
650	0	4	_aHepatitis B Surface Antigens _xanalysis
650	0	4	_aHepatitis B virus _xphysiology
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _ximmunology
650	0	4	_aInfliximab
650	0	4	_aLamivudine _xpharmacology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPsoriasis _xdrug therapy
650	0	4	_aReceptors, Tumor Necrosis Factor _ximmunology
650	0	4	_aRetrospective Studies
650	0	4	_aReverse Transcriptase Inhibitors _xpharmacology
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
650	0	4	_aVirus Latency _xdrug effects
700	1		_aMastrandrea, V
700	1		_aPrincipi, M
700	1		_aLoconsole, F
700	1		_aDe Tullio, N
700	1		_aDi Leo, A
700	1		_aVena, G A
773	0		_tJournal of biological regulators and homeostatic agents _gvol. 25 _gno. 2 _gp. 285-9
999			_c21122339 _d21122339